Literature DB >> 3011848

Development and application of monoclonal antibodies for specific detection of human enteric adenoviruses.

N Singh-Naz, R K Naz.   

Abstract

Monoclonal antibodies were prepared against enteric adenovirus by fusing P3-NS1/-Ag4-1 mouse myeloma cells with lymphocytes from BALB/c mice immunized with enteric adenovirus 40 (Ad40) G2297. Of the several putative clones secreting antibodies to adenovirus, five were found to react specifically to the enteric adenovirus. The specificity of two of these monoclones which recognize a single antigen of a molecular size of 17 kilodaltons was evaluated against 78 clinical isolates. One monoclone (5D8/2C2) reacted with both Ad40 and Ad41, and the other monoclone (2H6/C11) recognized Ad40 only in an enzyme-linked immunosorbent assay (ELISA). These ELISA results correlated well with those of the specific neutralization test or DNA restriction endonuclease analysis or both. The use of this rapid ELISA with these monoclones will find applications in the diagnosis of enteric adenovirus and should facilitate the epidemiologic studies of enteric adenovirus gastroenteritis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3011848      PMCID: PMC268733          DOI: 10.1128/jcm.23.5.840-842.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Cross-reactivity between enteric adenoviruses and adenovirus type 4: analysis of epitopes by solid-phase immune electron microscopy.

Authors:  L Svensson; G Wadell; I Uhnoo; M Johansson; C H Von Bonsdorff
Journal:  J Gen Virol       Date:  1983-11       Impact factor: 3.891

5.  Monoclonal antibody to a human germ cell membrane glycoprotein that inhibits fertilization.

Authors:  R K Naz; N J Alexander; M Isahakia; M S Hamilton
Journal:  Science       Date:  1984-07-20       Impact factor: 47.728

6.  Propagation and in vitro studies of previously non-cultivable enteral adenoviruses in 293 cells.

Authors:  H E Takiff; S E Straus; C F Garon
Journal:  Lancet       Date:  1981-10-17       Impact factor: 79.321

7.  Fecal adenoviruses from a longitudinal study of families in metropolitan Washington, D.C.: laboratory, clinical, and epidemiologic observations.

Authors:  W J Rodriguez; H W Kim; C D Brandt; R H Schwartz; M K Gardner; B Jeffries; R H Parrott; R A Kaslow; J I Smith; H Takiff
Journal:  J Pediatr       Date:  1985-10       Impact factor: 4.406

8.  Candidate adenoviruses 40 and 41: fastidious adenoviruses from human infant stool.

Authors:  J C de Jong; R Wigand; A H Kidd; G Wadell; J G Kapsenberg; C J Muzerie; A G Wermenbol; R G Firtzlaff
Journal:  J Med Virol       Date:  1983       Impact factor: 2.327

9.  Diagnosis of fastidious enteric adenoviruses 40 and 41 in stool specimens.

Authors:  M Brown; M Petric; P J Middleton
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

10.  Isolation and identification of enteric adenoviruses.

Authors:  R Wigand; H G Baumeister; G Maass; J Kühn; H J Hammer
Journal:  J Med Virol       Date:  1983       Impact factor: 2.327

View more
  14 in total

1.  DNA hybridization for diagnosis of enteric adenovirus infection from directly spotted human fecal specimens.

Authors:  G Hammond; C Hannan; T Yeh; K Fischer; G Mauthe; S E Straus
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 5.948

Review 2.  Adenovirus gastroenteritis.

Authors:  D J Wood
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-23

3.  Direct detection and differentiation of fastidious and nonfastidious adenoviruses in stools by using a specific nonradioactive probe.

Authors:  C Niel; S A Gomes; J P Leite; H G Pereira
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

4.  Preparation and characterization of monoclonal antibodies to enteric adenovirus types 40 and 41.

Authors:  J E Herrmann; D M Perron-Henry; D Stobbs-Walro; N R Blacklow
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

5.  Fast identification of adenovirus 40/41 in infants with enteritis.

Authors:  R Wigand
Journal:  Eur J Clin Microbiol       Date:  1987-10       Impact factor: 3.267

6.  Monoclonal antibody enzyme-linked immunosorbent assay for specific identification and typing of subgroup F adenoviruses.

Authors:  N Singh-Naz; W J Rodriguez; A H Kidd; C D Brandt
Journal:  J Clin Microbiol       Date:  1988-02       Impact factor: 5.948

7.  Detection, typing, and subtyping of enteric adenoviruses 40 and 41 from fecal samples and observation of changing incidences of infections with these types and subtypes.

Authors:  J C de Jong; K Bijlsma; A G Wermenbol; M W Verweij-Uijterwaal; H G van der Avoort; D J Wood; A S Bailey; A D Osterhaus
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

8.  Prevalence of enteric adenovirus from acute gastroenteritis: a five year study.

Authors:  R Cevenini; R Mazzaracchio; F Rumpianesi; M Donati; A Moroni; V Sambri; M La Placa
Journal:  Eur J Epidemiol       Date:  1987-06       Impact factor: 8.082

Review 9.  Clinical laboratory applications of monoclonal antibodies.

Authors:  W J Payne; D L Marshall; R K Shockley; W J Martin
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

10.  Prevalent enteric adenovirus variant not detected by commercial monoclonal antibody enzyme immunoassay.

Authors:  T Scott-Taylor; G Ahluwalia; B Klisko; G W Hammond
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.